BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Borren NZ, Tan W, Colizzo FP, Luther J, Garber JJ, Khalili H, van Der Woude CJ, Ananthakrishnan AN. Longitudinal Trajectory of Fatigue With Initiation of Biologic Therapy in Inflammatory Bowel Diseases: A Prospective Cohort Study. Journal of Crohn's and Colitis 2020;14:309-15. [DOI: 10.1093/ecco-jcc/jjz148] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Barberio B, Zamani M, Black CJ, Savarino EV, Ford AC. Prevalence of symptoms of anxiety and depression in patients with inflammatory bowel disease: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol 2021;6:359-70. [PMID: 33721557 DOI: 10.1016/S2468-1253(21)00014-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 9.0] [Reference Citation Analysis]
2 McGing JJ, Radford SJ, Francis ST, Serres S, Greenhaff PL, Moran GW. Review article: The aetiology of fatigue in inflammatory bowel disease and potential therapeutic management strategies. Aliment Pharmacol Ther 2021;54:368-87. [PMID: 34228817 DOI: 10.1111/apt.16465] [Reference Citation Analysis]
3 Ghosh S, Sensky T, Casellas F, Rioux LC, Ahmad T, Márquez JR, Vanasek T, Gubonina I, Sezgin O, Ardizzone S, Kligys K, Petersson J, Suzuki Y, Peyrin-Biroulet L. A Global, Prospective, Observational Study Measuring Disease Burden and Suffering in Patients with Ulcerative Colitis Using the Pictorial Representation of Illness and Self-Measure Tool. J Crohns Colitis 2020:jjaa159. [PMID: 32722760 DOI: 10.1093/ecco-jcc/jjaa159] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Varbobitis I, Kokkotis G, Gizis M, Perlepe N, Laoudi E, Bletsa M, Bekiari D, Koutsounas I, Kounadis G, Xourafas V, Lagou S, Kolios G, Papakonstantinou I, Bamias G. The IBD-F Patient Self-Assessment Scale Accurately Depicts the Level of Fatigue and Predicts a Negative Effect on the Quality of Life of Patients With IBD in Clinical Remission. Inflamm Bowel Dis 2021;27:826-35. [PMID: 32766770 DOI: 10.1093/ibd/izaa201] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Emerson C, Barhoun P, Olive L, Fuller-Tyszkiewicz M, Gibson PR, Skvarc D, Mikocka-Walus A. A systematic review of psychological treatments to manage fatigue in patients with inflammatory bowel disease. J Psychosom Res 2021;147:110524. [PMID: 34034138 DOI: 10.1016/j.jpsychores.2021.110524] [Reference Citation Analysis]
6 Thomas PWA, den Broeder N, Derikx M, Kievit W, West RL, Russel MGVM, Jansen JM, Römkens TEH, Hoentjen F. Impact of Biological Therapies and Tofacitinib on Real-world Work Impairment in Inflammatory Bowel Disease Patients: A Prospective Study. Inflamm Bowel Dis 2022:izac002. [PMID: 35134917 DOI: 10.1093/ibd/izac002] [Reference Citation Analysis]
7 Yzet C, Brazier F, Sebbagh V, Vanelslander P, Dejour V, David B, Nguyen-khac E, Diouf M, Fumery M. Complete Endoscopic Healing is Associated with Lower Disability than Partial Endoscopic Healing in Crohn's Disease: a Prospective Multicenter Study. Clinics and Research in Hepatology and Gastroenterology 2022. [DOI: 10.1016/j.clinre.2022.101887] [Reference Citation Analysis]
8 Borren NZ, Tan W, Jess AT, Li PM, Garber JJ, Luther J, Colizzo FP, Khalili H, Ananthakrishnan AN. Assessment of Body Weight Changes in Patients with Inflammatory Bowel Diseases Initiating Biologic Therapy: A Prospective Cohort Study. Dig Dis Sci 2020;65:3672-8. [PMID: 32617768 DOI: 10.1007/s10620-020-06442-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Rogler G, Singh A, Kavanaugh A, Rubin DT. Extraintestinal Manifestations of Inflammatory Bowel Disease: Current Concepts, Treatment, and Implications for Disease Management. Gastroenterology 2021:S0016-5085(21)03337-0. [PMID: 34358489 DOI: 10.1053/j.gastro.2021.07.042] [Reference Citation Analysis]
10 Truyens M, De Ruyck E, Gonzales GB, Bos S, Laukens D, De Vos M. Prevalence of Fatigue and Unrecognized Depression in Patients with Inflammatory Bowel Disease in Remission under Immunosuppressants and Biologicals. J Clin Med 2021;10:4107. [PMID: 34575218 DOI: 10.3390/jcm10184107] [Reference Citation Analysis]
11 Langbrandtner J, Steimann G, Reichel C, Bokemeyer B, Hüppe A. Berufsbezogene Problemlagen und erwünschte Unterstützungsangebote bei chronisch entzündlichen Darmerkrankungen: Ergebnisse einer multiperspektivischen Erhebung. Rehabilitation (Stuttg) 2021;60:29-36. [DOI: 10.1055/a-1248-5703] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Davis SP, Chen DG, Crane PB, Bolin LP, Johnson LA, Long MD. Influencing Factors of Inflammatory Bowel Disease-Fatigue: A Path Analysis Model. Nurs Res 2021;70:256-65. [PMID: 33935213 DOI: 10.1097/NNR.0000000000000517] [Reference Citation Analysis]
13 Rozich JJ, Holmer A, Singh S. Effect of Lifestyle Factors on Outcomes in Patients With Inflammatory Bowel Diseases. Am J Gastroenterol 2020;115:832-40. [PMID: 32224703 DOI: 10.14309/ajg.0000000000000608] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
14 Borren NZ, Long MD, Sandler RS, Ananthakrishnan AN. Longitudinal Trajectory of Fatigue in Patients With Inflammatory Bowel Disease: A Prospective Study. Inflamm Bowel Dis 2020:izaa338. [PMID: 33367749 DOI: 10.1093/ibd/izaa338] [Cited by in F6Publishing: 1] [Reference Citation Analysis]